Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

Research Network

Collaboration Network

32 collaborators·69 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Maryland Greenebaum Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

John Alexander, MD

Duke Clinical Research Institute

Moderately Similar
2 trials

Shared therapeutic areas:

Heparin Induced Thrombocytopenia
Similarity Score30%

Nigel Key, MD

University of North Carolina, Chapel Hill

Related
4 trials

Shared therapeutic areas:

Heparin Induced Thrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score14%

Thomas Raife, MD

University of Iowa

Related
3 trials

Shared therapeutic areas:

Heparin Induced Thrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score14%

Barbara Konkle, MD

Bloodworks

Related
1 trials

Shared therapeutic areas:

Heparin Induced Thrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score14%

Joseph Kiss, MD

University of Pittsburgh Institute for Transfusion Medicine

Related
1 trials

Shared therapeutic areas:

Heparin Induced Thrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score14%

Thomas Ortel, MD PHD

Duke University

Related
1 trials

Shared therapeutic areas:

Heparin Induced Thrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score14%

Jeffrey McCullough, MD

University of Minnesota

Related
5 trials

Shared therapeutic areas:

Heparin Induced Thrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score14%

Susan F Assmann, PhD

Carelon Research

Related
3 trials

Shared therapeutic areas:

Heparin Induced Thrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score14%

Ellis Neufeld, MD PHD

Boston Children's Hospital

Related
1 trials

Shared therapeutic areas:

Heparin Induced Thrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score14%

Jodi Segal, MD MPH

Johns Hopkins University

Related
1 trials

Shared therapeutic areas:

Heparin Induced Thrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01178333PrincipalInvestigator

Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study

Heparin Induced Thrombocytopenia
Completed

All 1 trials loaded